Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-25-004572
Filing Date
2025-04-23
Accepted
2025-04-23 16:10:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 tennx_424b3.htm 424B3 125497
2 tennx_s3img1.jpg GRAPHIC 4493
3 tennx_s3img2.jpg GRAPHIC 4493
  Complete submission text file 0001654954-25-004572.txt   139469
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286557 | Film No.: 25861566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)